Advertisement

Table of Contents

January 01, 1996; Volume 49,Issue 1

You have access
Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.
A Schrattenholz, E F Pereira, U Roth, K H Weber, E X Albuquerque and A Maelicke

Molecular Pharmacology January 1996, 49 (1) 1-6;
You have access
Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.
E Nisoli, C Tonello, M Landi and M O Carruba

Molecular Pharmacology January 1996, 49 (1) 7-14;
You have access
Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
H Kleinert, C Euchenhofer, I Ihrig-Biedert and U Förstermann

Molecular Pharmacology January 1996, 49 (1) 15-21;
You have access
Characterization of the G protein involved in the muscarinic stimulation of adenylyl cyclase of rat olfactory bulb.
M C Olianas and P Onali

Molecular Pharmacology January 1996, 49 (1) 22-29;
You have access
Coexpression of beta 1 with cardiac sodium channel alpha subunits in oocytes decreases lidocaine block.
J C Makielski, J T Limberis, S Y Chang, Z Fan and J W Kyle

Molecular Pharmacology January 1996, 49 (1) 30-39;
You have access
Ethanol increases the activity of large conductance, Ca(2+)-activated K+ channels in isolated neurohypophysial terminals.
A M Dopico, J R Lemos and S N Treistman

Molecular Pharmacology January 1996, 49 (1) 40-48;
You have access
Palytoxin-induced Na+ influx into yeast cells expressing the mammalian sodium pump is due to the formation of a channel within the enzyme.
J Redondo, B Fiedler and G Scheiner-Bobis

Molecular Pharmacology January 1996, 49 (1) 49-57;
You have access
Inhibition of human interferon-gamma biosynthesis by an antisense RNA-expressing vector.
C M Boeve, A V Wyngaerd and M De Ley

Molecular Pharmacology January 1996, 49 (1) 58-62;
You have access
Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
J D Schuetz, E G Schuetz, J V Thottassery, P S Guzelian, S Strom and D Sun

Molecular Pharmacology January 1996, 49 (1) 63-72;
You have access
Thiophosphorylation of the G protein beta subunit in human platelet membranes: evidence against a direct phosphate transfer reaction to G alpha subunits.
M Hohenegger, T Mitterauer, T Voss, C Nanoff and M Freissmuth

Molecular Pharmacology January 1996, 49 (1) 73-80;
You have access
Protein kinase C isozyme-specific modulation of cyclic AMP-dependent phosphodiesterase in hypertrophic cardiomyopathic hamster hearts.
J J Cai and H C Lee

Molecular Pharmacology January 1996, 49 (1) 81-88;
You have access
The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization.
S A Laporte, G Servant, D E Richard, E Escher, G Guillemette and R Leduc

Molecular Pharmacology January 1996, 49 (1) 89-95;
You have access
Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells.
H Kai, T Fukui, B Lassègue, A Shah, C A Minieri and K K Griendling

Molecular Pharmacology January 1996, 49 (1) 96-104;
You have access
Stereoselective and regioselective hydration of 7-methylbenz[c]acridine-5,6-oxide enantiomers by rodent and human microsomal epoxide hydrolases.
S J Roberts-Thomson, M E McManus, C C Duke, R Agnew and G M Holder

Molecular Pharmacology January 1996, 49 (1) 105-111;
You have access
Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor.
D M Perez, J Hwa, R Gaivin, M Mathur, F Brown and R M Graham

Molecular Pharmacology January 1996, 49 (1) 112-122;
You have access
Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466.
M Kessler, A Arai, A Quan and G Lynch

Molecular Pharmacology January 1996, 49 (1) 123-131;
You have access
Single amino acid substitutions in the pm2 muscarinic receptor alter receptor/G protein coupling without changing physiological responses.
D A Bulseco and M I Schimerlik

Molecular Pharmacology January 1996, 49 (1) 132-141;
You have access
Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655.
K M Partin and M L Mayer

Molecular Pharmacology January 1996, 49 (1) 142-148;
You have access
Mitogenic effects of tetrahydrobiopterin in PC12 cells.
P Z Anastasiadis, J C States, B A Imerman, M C Louie, D M Kuhn and R A Levine

Molecular Pharmacology January 1996, 49 (1) 149-155;
You have access
Specific and effective interaction of a guanine nucleotide analogue with small G proteins.
S Hoffenberg, T M Shannon, T P Noonan, S Liu, D S Daniel, J B Fishman, J B Rubins, H K Misra, G E Wright and B F Dickey

Molecular Pharmacology January 1996, 49 (1) 156-164;
You have access
Structure-activity relationship of quaternary ammonium ions at the external tetraethylammonium binding site of cloned potassium channels.
W Jarolimek, K V Soman, M Alam and A M Brown

Molecular Pharmacology January 1996, 49 (1) 165-171;
You have access
Phenytoin-initiated hydroxyl radical formation: characterization by enhanced salicylate hydroxylation.
P M Kim and P G Wells

Molecular Pharmacology January 1996, 49 (1) 172-181;
You have access
Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.
R B Clark, C Allal, J Friedman, M Johnson and R Barber

Molecular Pharmacology January 1996, 49 (1) 182-189;
You have access
Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
S M Seiler, M Peluso, J G Tuttle, K Pryor, C Klimas, G R Matsueda and M S Bernatowicz

Molecular Pharmacology January 1996, 49 (1) 190-197;
You have access
The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.
R A Glennon, M Dukat, R B Westkaemper, A M Ismaiel, D G Izzarelli and E M Parker

Molecular Pharmacology January 1996, 49 (1) 198-206;